Immunoadjuvant activity of a liposomal IL-6 formulation.

[1]  M. Lenardo lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.

[2]  A. Duits,et al.  Selective Enhancement of Leu Cam Expression by Interleukin 6 during Differentiation of Human Promonocytic U937 Cells , 1991, Scandinavian journal of immunology.

[3]  J. Playfair,et al.  Conjugation of interferon-gamma to antigen enhances its adjuvanticity. , 1990, Immunology.

[4]  S. Rosenberg,et al.  Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.

[5]  G. Gregoriadis,et al.  Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators. , 1989, Immunology.

[6]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[7]  Toshio Hirano,et al.  Genes coding for RNA polymerase β subunit in bacteria , 1988 .

[8]  T. Hirano,et al.  Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. , 1988 .

[9]  T. Hirano,et al.  Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. , 1988, Journal of immunology.

[10]  L. Aarden,et al.  Functional discrimination between interleukin 6 and interleukin 1 , 1988, European journal of immunology.

[11]  A Muraguchi,et al.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells , 1988, The Journal of experimental medicine.

[12]  L. Aarden,et al.  Molecular cloning and expression of hybridoma growth factor in Escherichia coli. , 1987, Journal of immunology.

[13]  G. Gregoriadis,et al.  Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. , 1987, Immunology.

[14]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Gregoriadis Immunological adjuvants: a role for liposomes. , 1990, Immunology today.

[16]  F. Audibert,et al.  Immunoadjuvants and analogs of immunomodulatory bacterial structures. , 1989, Current opinion in immunology.

[17]  D. Gerlier,et al.  Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidyl‐ethanolamine linked to the secretion of prostaglandins by macrophages , 1987, European journal of immunology.

[18]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.